AnaptysBio (ANAB) announced that its board of directors has authorized an amended stock repurchase plan under which the company may repurchase up to $100M of the company’s outstanding common stock, par value $0.001 per share. This amendment is in addition to the $6.4M that remained as of Nov. 20 under the current $75M stock repurchase plan of which Anaptys has repurchased a total of 3,443,188 shares of common stock.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANAB: